Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Efficacy of QingyiHuaji Optimized Formula Combined With Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer: a Prospective, Multicenter, Randomized Controlled Clinical Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05840341
Title field or adapter rule
{'original_value': 'Clinical Efficacy of QingyiHuaji Optimized Formula Combined With Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer: a Prospective, Multicenter, Randomized Controlled Clinical Study', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:26.596841+00:00
Published At
2026-09-03T00:00:00+00:00
Record Updated At
2026-09-03
Source Retrieved At
2026-10-31T22:17:58.991924+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pancreatic Neoplasms"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-09-03", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT05840341"
protocolSection.identificationModule.officialTitle
"Clinical Efficacy of QingyiHuaji Optimized Formula Combined With Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer: a Prospective, Multicenter, Randomized Controlled Clinical Study"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Pancreatic Neoplasms (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Experimental group'], 'description': 'Qingyihuaji Optimization Formula each bag contains: (1)Scutellaria barbata D. Don (Banzhilian); (2) Hedyotis diffusa Willd. (Sheshecao); (3) Amorphophallus rivieri Durieu (Sheliugu); (4) Amomi Fructus Rotundus (Doukou); (5) Gynostemma pentaphyllum (Thunb.) Makino (Jiaogulan); (6) Semen Coicis (Yiyiren); (7) Ganoderma lucidum (Curtis) P. Karst. (Lingzhi). One bag at a time, twice a day, rinsing with boiling water, continuous administration, oral administration in the morning and evening, every 3 weeks as a cycle.', 'name': 'QingyiHuaji optimized formula', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Placebo group'], 'description': 'The sensory-matched placebo was manufactured to resemble QYHJ optimized formula in appearance, color, taste, odor, packaging, labeling, and administration schedule. Each placebo sachet contained 2% QYHJ granules, 86.13% maltodextrin, 10% lactose, 1.28% caramel pigment, 0.08% lemon-yellow pigment, 0.01% sunset-yellow pigment, and 0.50% bittering agent. Participants took one 8-g sachet orally twice daily, in the morning and evening, after reconstitution with boiling water. Treatment was administered continuously, with each 3-week period defined as one study-product cycle.', 'name': 'Matched placebo', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • QingyiHuaji optimized formula (protocolSection.armsInterventionsModule.interventions[].name)
  • Matched placebo (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.